Status:
COMPLETED
Post Marketing Surveillance Study in Patients With Idiopathic Parkinson's Disease
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Parkinson Disease
Eligibility:
All Genders
Brief Summary
Documentation of the effect of an direct or overlapping switch from another dopamine agonist to Sifrol® on motor function, psychopathological disturbances and mood, assessment of the reasons for the s...
Eligibility Criteria
Inclusion
- Patients with Idiopathic Parkinson's disease who are planned to undergo a switch from another dopamine agonist to Sifrol®
Exclusion
- Neurologists and psychiatrists are asked to consider the Summary of Product Characteristics (SPC) for Sifrol®
Key Trial Info
Start Date :
February 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
1216 Patients enrolled
Trial Details
Trial ID
NCT02231255
Start Date
February 1 2002
Last Update
September 17 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.